KIN - Kindred Biosciences,...

Valuation of Kindred Biosciences, Inc.(KIN), Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the li

photo-url-https://financialmodelingprep.com/image-stock/KIN.jpg

Kindred Biosciences, Inc.

KIN

NASDAQ

Inactive Equity

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

9.25 USD

0.01000023 (0.108%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Dec 31, 1969 7:00 PM

Share Price on Valuation Date

$9.25

Stock Beta

1.315223

Shares Outstanding

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.